头颈癌放疗后味觉障碍的全口味觉测试与临床及患者报告结局的纵向比较及其与经口摄入的关联
结果显示主观报告比全口味觉测试反映更明显的味觉损伤,最显著下降发生于治疗中期;化疗所致味觉改变量表的不适子量表与维持经口饮食、经口摄入百分比和食欲水平显著相关。结论认为患者报告结局提示持续存在的经口摄入问题,全口味觉测试可能无法完全反映功能性味觉丧失。
要点
- 主观报告比全口味觉测试更能反映头颈癌放疗后的味觉损伤。
- 味觉下降最显著且一致的时期为治疗中期。
- 化疗所致味觉改变量表不适子量表与经口摄入及食欲相关。
核心结论
- 患者报告结局提示头颈癌放疗后持续存在经口摄入问题。
- 全口味觉测试可能无法完全反映功能性味觉丧失。
- 需要味觉障碍的预防和治疗方法以改善患者结局。
研究设计与样本
- 在基线、治疗第2周和第4周以及治疗后1、3、6个月进行评估。
- 使用全口味觉测试及相关的临床医生评定和主观患者报告测量。
主要发现
- 主观报告比全口味觉测试反映更明显的味觉损伤。
- 最显著且一致的味觉下降发生在治疗中期。
- 化疗所致味觉改变量表的不适子量表从治疗中期至治疗后6个月与维持经口饮食、经口摄入百分比和食欲水平显著相关。
临床怎么用
- 在头颈癌放疗后味觉评估中应重视患者报告结局。
- 全口味觉测试结果需结合主观报告综合判断功能性味觉丧失。
- 关注治疗中期至治疗后6个月的味觉相关不适对经口摄入的影响。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After head and neck cancer (HNC) treatment, dysgeusia may be a barrier to oral intake. In this exploratory study, we prospectively examined taste perception, clinician-rated (CRO) and patient-reported (PRO) taste changes and their effect on oral intake postradiotherapy. METHODS: Twenty-eight patients were assessed at baseline, treatment weeks 2 and 4, and 1, 3, and 6 months post-treatment using a whole-mouth taste test and associated CRO and subjective PRO measures. RESULTS: Greater taste impairment was reflected by subjective than by a whole-mouth taste test. The most significant and consistent decline occurred mid-treatment. The Chemotherapy-Induced Taste Alteration Scale (PRO) discomfort subscale correlated significantly with maintaining an oral diet, percent of oral intake, and appetite level from mid-treatment to 6 months post-treatment. CONCLUSIONS: PRO results indicated ongoing oral intake issues. Whole-mouth taste tests may fail to fully reflect functional taste-loss. Dysgeusia prevention and treatment methods are needed to improve patient outcomes.
引用
- Messing BP, Ward EC, Lazarus C, et al. Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake. Head Neck. 2021. PMID: 33856086. doi:10.1002/hed.26690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。